Shelley, Karishma
Articolo, Amy
Luthra, Rakesh
Charlton, Michael
Funding for this research was provided by:
Novo Nordisk, Inc
Article History
Received: 19 December 2022
Accepted: 30 April 2023
First Online: 19 May 2023
Declarations
:
: This study was a non-interventional, cross-sectional database study utilizing the Ipsos syndicated NASH Therapy Monitor database. All methods were carried out in accordance with relevant guidelines and regulations. The clinical data of the patients was collected from the database, and all of the data were anonymized before we used it in this study. There were not any administrative permissions required to access the raw data used in our study.
: Not applicable.
: AA and RL are employees of, and own stock in, Novo Nordisk Inc. KS was an employee of Novo Nordisk Inc. at the time the study was conducted. MC is a consultant and study investigator for Novo Nordisk and Terns; a consultant for Histoindex, Celgene, Bristol Myers, Akera, and Theratechnologies; and an investigator for Madrigal and Northsea.